Magnus Jäderberg

Statistics

Publications

Citations

851

H-Index

Active since

1991

Affiliations

Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy(Current)

Targovax (Norway)

Targovax (Finland)

University of Helsinki

Oncos Therapeutics (Finland)

Magnus Jäderberg is an author at Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy specializing in oncology, cancer immunotherapy, and tumor immunology.

ORCID

Publications per year

1991–2023

Publications

Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers

Tuuli Ranki, Sari Pesonen, Akseli Hemminki et al. · Journal for ImmunoTherapy of Cancer · 2016 · 202 citations · Full text

Pharmacy, Immunology, Oncology +17

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.

Michael Lancaster-Smith, Magnus Jäderberg, D. Jackson · Gut · 1991 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model

Łukasz Kuryk, Anne‐Sophie W. Møller, Magnus Jäderberg · OncoImmunology · 2018 · 101 citations · Full text

Medicine, Immunology, Oncology +17

Comparison of minimal and conventional surgery in patients with bleeding peptic ulcer: A multicentre trial

V Poxon, M R B Keighley, P W Dykes et al. · British journal of surgery · 1991 · 70 citations

Medicine, Surgery, Gastroenterology +10

Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup>T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer

Lotta Vassilev, Tuuli Ranki, Timo Joensuu et al. · OncoImmunology · 2015 · 56 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 14